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Abstract
Background: The recent West Nile virus (WNV) outbreaks in developed countries, including Europe and the United States,
have been associated with significantly higher neuropathology incidence and mortality rate than previously documented.
The changing epidemiology, the constant risk of (re-)emergence of more virulent WNV strains, and the lack of effective
human antiviral therapy or vaccines makes understanding the pathogenesis of severe disease a priority. Thus, to gain
insight into the pathophysiological processes in severe WNV infection, a kinetic analysis of protein expression profiles in the
brain of WNV-infected mice was conducted using samples prior to and after the onset of clinical symptoms.
Methodology/Principal Findings: To this end, 2D-DIGE and gel-free iTRAQ labeling approaches were combined, followed
by protein identification by mass spectrometry. Using these quantitative proteomic approaches, a set of 148 proteins with
modified abundance was identified. The bioinformatics analysis (Ingenuity Pathway Analysis) of each protein dataset
originating from the different time-point comparisons revealed that four major functions were altered during the course of
WNV-infection in mouse brain tissue: i) modification of cytoskeleton maintenance associated with virus circulation; ii)
deregulation of the protein ubiquitination pathway; iii) modulation of the inflammatory response; and iv) alteration of
neurological development and neuronal cell death. The differential regulation of selected host protein candidates as being
representative of these biological processes were validated by western blotting using an original fluorescence-based
method.
Conclusion/Significance: This study provides novel insights into the in vivo kinetic host reactions against WNV infection
and the pathophysiologic processes involved, according to clinical symptoms. This work offers useful clues for anti-viral
research and further evaluation of early biomarkers for the diagnosis and prevention of severe neurological disease caused
by WNV.
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Introduction
West Nile virus (WNV) is a small, enveloped, positive-stranded
RNA virus belonging to the Flaviviridae family (genus Flavivirus).
This arbovirus is widespread, occurring on all continents with the
exception of Antarctica [1]. Since its isolation from a febrile
woman in Uganda in 1937 [2], WNV has been responsible of high
morbidity and mortality in infected birds, horses and humans [3].
WNV is maintained in nature in enzootic cycles involving mainly
ornithophilic mosquitoes, predominantly Culex species, and avian
hosts. Transmission to other vertebrates, such as horses or
humans, occurs incidentally [4]. Therefore, horses or humans
are considered incidental or ‘‘dead-end’’ hosts due to the
insufficient blood viremia to infect a naı¨ve feeding mosquito.
Although human WNV infections are asymptomatic in more than
80% of cases, 1% of persons with clinical illness could develop
neurologic symptoms such as meningitis, encephalitis and acute
flaccid paralysis, with low mortality rates [5]. Severe disease may
be life-threatening to susceptible individuals such as the very
young, the elderly and immunocompromised patients [6].
The epidemiology of WNV changed in the 1990s and is now
characterized by the increasing incidence of neuroinvasive
symptoms in humans in the Mediterranean basin (i.e., Algeria,
Tunisia, Italy, Romania, Israel, France, Portugal, Spain and
Hungary) and Russia [7,8,9,10,11,12]. Moreover, the emergence
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of WNV in the summer of 1999 in the U.S. was responsible for the
largest arboviral epidemic of human encephalitis in history, and it
continues to be the most frequent cause of epidemic meningoen-
cephalitis in North America [13]. Since then, WNV has spread
throughout the American continent and has recently been
reported in Mexico, South America, and the Caribbean [14].
WNV is now considered endemic in Africa, Asia, Australia, the
Middle East, Europe and the United States [15]. In 2010, WNV
emerged in Greece, resulting in 262 confirmed cases with 81
patients presenting with neurological manifestations and mortality
rates of 9.9% [16]. Two main phylogenetic lineages of WNV have
been described [17], with a higher incidence of neuroinvasive
disease associated with subtypes of WNV lineage I. Lineage I
strains have been more frequently detected in the recent European
outbreaks [18].
The changing epidemiology, the constant risk of (re-)emergence
of more virulent strains, and the lack of effective antiviral therapy
or vaccines, makes understanding the pathogenesis of severe
disease a priority [5]. Recent technological advances in genomics
and proteomics have greatly improved our knowledge of the
pathophysiological processes following virus infections [19,20]. For
example, DNA microarrays have been utilized to dissect the
transcriptomic profiles in cultured cells infected with WNV [21]
and to compare the neurovirulence of different WNV strains [22].
The authors showed that several genes involved in antiviral
responses were up-regulated following WNV infection. Several
genes involved in interferon-stimulated genes (ISGs), development
of the immune response and cell apoptosis were differentially
expressed. These molecular changes could represent different
functions, some contributing to neurovirulence and others
participating in the response to infection. Similarly, a global
transcriptional analysis of human glioblastoma cells infected with
WNV reported differential expression of 173 host genes, among
which a subset participated in the regulation of diverse physiologic
processes, such as immunity, apoptosis, the ubiquitin cycle and the
regulation of transcription [23]. Recently, gene expression profiles
in the central nervous system from horses infected with WNV were
compared [24]. Significant changes were detected according to
WNV exposure and/or vaccination, particularly in neurological,
immunological and apoptotic pathways.
At the protein level, in vitro experiments carried out on Vero and
neuronal cell cultures showed profound host modifications of the
proteome following WNV infection [25,26]. It was shown that a
large majority of proteins were up-regulated, including proteins
belonging to the apoptotic pathway, cell cycle regulation or
maintenance of the cytoskeleton network. Although the precise
mechanisms of these proteome alterations are still unclear, these
changes could be attributed to two complementary phenomena: a
viral manipulation of host proteins to successfully complete viral
replication or a response from the host to counteract viral
infection. However, analyses of the transcriptomic and proteomic
profiles in the brain of susceptible animals after infection with
WNV, considering clinical onset evolution, have not yet been
described. Elucidating the protein interaction networks and the
use of pathway-based analysis may provide an effective approach
to investigate the molecular mechanisms of WNV neuroinvasive
disease.
To gain insights into the pathophysiological processes in severe
WNV infection, a kinetic analysis of protein expression profiles in
the brain of WNV-infected mice was conducted using samples
prior to and after the onset of clinical symptoms. To this end, 2D-
DIGE and gel-free iTRAQ labeling approaches were combined,
followed by protein identification by mass spectrometry. Using
these quantitative proteomic approaches, a set of altered proteins
was identified. The dataset was analyzed using ingenuity pathway
analysis (IPA), which enabled the identification of functional
signaling networks in samples collected during early and late
infection. The results were subsequently translated into biological
processes that may be involved in the pathogenesis of neuroinva-
sive disease caused by WNV infection.
Materials and Methods
Ethics Statement
All animal experiments described in this paper have been
conducted according to Dutch guidelines for animal experimen-
tation and approved by the Animal Welfare Committee of the
Erasmus Medical Centre, Rotterdam, Netherlands. All efforts
were made to minimize animal suffering.
Reagents
N-hydroxy succinimide ester Cy2, Cy3 and Cy5, urea, glycerol,
mineral oil, immobiline DryStrip gel (18 cm, pH = 3–10, pH = 4–
7 and pH = 6–11) and IPG buffer solutions (pH = 3–10, 4–7 and
6–11) were purchased from GE Healthcare (Piscataway, NJ).
Acrylamide, DTT, Tris, glycine and SDS were purchased from
Bio-Rad (Hercules, CA, USA). Dimethyl formamide (DMF),
CHAPS, L-lysine, ammonium persulfate, iodoacetamide, agarose,
bromophenol blue and TFA were purchased from Aldrich (Poole,
Dorset, UK). Thiourea, TEMED, acetone, acetonitrile (ACN) and
ethanol were purchased from Fluka (Buchs, Switzerland). Trypsin
(sequencing grade) was purchased from Promega (Madison, WI).
All buffers were prepared with Milli-Q water (Millipore, Belford,
MA, USA). ImperialTM Protein Stain solution was purchased from
Thermo Scientific (Rockford, IL, USA).
Cells and Virus
Vero E6 cells were grown in DMEM (Lonza Benelux BV,
Breda, Netherlands) supplemented with antibiotics, 10% heat
inactivated fetal calf serum (FCS), sodium bicarbonate and 10 mM
HEPES buffer (all from Lonza). The prototype NY99 WNV strain
(accession AF196835.2, obtained from the Health Protection
Agency, Porton Down, UK; P5 on Vero E6 cells) was used for the
infection of mice. The 50% tissue culture infectious dose (TCID50)
was determined on VeroE6 cells using the Spearman & Ka¨rber
method based on the presence of cytopathic effects five days post
inoculation [27,28].
Mouse Infection
Twenty nine-day old female C57/BL6 mice (Harlan Labora-
tories B.V., Venray, Netherlands) were inoculated intraperitone-
ally (i.p.) with 105 TCID50 WNV-NY99. Five animals were
euthanized by cervical dislocation under isoflurane anesthesia on
days 3, 4, 5 and 6 post-inoculation, and brains were collected for
further processing to determine virus titers in the brain. The results
of this first kinetics mouse experiment were used to determine the
early and late time-point of virus infection in the brain. Following
this experiment, 12 nine-day old female C57/BL6 mice were
inoculated i.p. with 105 TCID50 WNV-NY99. Six animals
infected with WNV were euthanized by cervical dislocation under
isoflurane anesthesia on days 3 (early; WNV-E1 to E6) and 5 (late;
WNV-L1 to L6) post-infection. Six animals were inoculated with
DMEM (mock group; C1 to C6) and euthanized on day 2 to
eliminate the influence of LPS production incurred by damage as
a result of the injection. Brains were collected following
euthanization, and half of the brain (left hemisphere; no
cerebellum) was washed gently once with ice-cold PBS and frozen
at 280uC until further use (see Protein sample preparation below).
Host Response to Severe WNV Infection
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Mice were maintained in isolator cages throughout the infection
experiment, had a 12-hour day-night cycle and were fed ad libitum.
Animal experiments were approved by the Animal Ethics
Committee of Erasmus Medical Center.
Quantitation of Virus in the Brain
To quantify viral burden in the brain from the first kinetics
mouse experiment, a half brain was weighed and homogenized
using a metal bead in 1 mL DMEM containing antibiotics (100 U
penicillin, 100 mg/mL streptomycin) using a tissue homogenizer.
Brains of infected animals euthanized at the early and late time-
point were removed and stored in AmbionH RNA-later (Invitro-
gen, Bleiswijk, Netherlands). RNA was isolated from the brain
tissues using Trizol reagent (Invitrogen) and the RNeasy Mini kit
(Qiagen). WNV RNA copy numbers in the brain were determined
using positive-sense strand-specific qRT-PCR, as described by
Lanford et al. [29], with the TaqmanH EZ RT-PCR kit (Applied
Biosystems, Bleiswijk, Netherlands) and primers and probe located
on the 39UTR of WNV. RNA copy numbers were quantified
using a standard curve of in vitro transcribed RNA of known
quantities. Run-off transcripts were generated from a plasmid
containing the sequence of the 39 UTR of WNV-NY99. Briefly,
‘tagged primers’ were generated by adding a 32-mer-long
sequence of the Grapevine virus A as a tag at the 59-end of the
respective primers. Specific detection of the WNV-positive RNA
strand was performed after cDNA synthesis using a tagged reverse
primer, complimentary to the positive-sense strand and subse-
quently, the positive strand was amplified using the tagged
sequence as the reverse primer and a WNV-specific unmodified
forward primer. This procedure has been reported to prevent the
amplification of cDNA products that are made by the false
priming of either the positive or negative RNA strand as well as
the amplification of cDNA acquired as a result of self-priming
[29]. All RT reactions contained 30 pmol primer and were carried
out for 2 min at 50uC and 30 min at 60uC using the rTth RT
enzyme according to the instructions provided by the TaqmanH
EZ RT-PCR kit (Applied Biosystems).
Immunohistology
Sagittal brain 4-mm thick paraffin sections were processed for
streptavidin-biotin-peroxidase immunohistochemistry of virus
nonstructural protein. Sections were deparaffinized in xylene,
rehydrated in descending concentrations of ethanol and incubated
for 10 min in 3% H2O2 diluted in PBS to block endogenous
peroxidase activity. Antigen exposure was performed by incuba-
tion for 15 min at 121uC in citrate buffer (0.01 M, pH 6.0).
Sections were incubated overnight at 4uC with a primary goat
anti-WNV nonstructural protein 3 (NS3) antibody (1:100; R&D
Systems, Abingdon, UK) and were detected using a secondary
rabbit anti-goat IgG-peroxidase antibody (Dako, Eindhoven, The
Netherlands). Sections were counterstained with Mayer’s hema-
toxylin and mounted with Kaiser’s glycerin-gelatin and analyzed
using a light microscope.
Protein Sample Preparation
For protein preparation, each brain sample was lysed with 1 ml
of lysis buffer containing 2% SDS, 125 mM Tris-HCl pH = 6.8,
10% glycerol and 5% mercaptoethanol, and homogenised by
mechanical disruption using metal beads and the Tissue Lyser
apparatus (QIAGEN). The resulting homogenates were centri-
fuged for 15 min at 16 0006g at 4uC and the supernatant was
collected and stored at 280uC. The protein concentration of each
sample was determined by the Lowry method (DC Protein assay
Kit, Bio-Rad) according to the manufacturer’s instructions.
Protein concentration of each mouse brain sample homogenate
ranged from 7.3 to 14.3 mg/ml.
CyDye Labeling
Samples were subjected to 2-D clean-up kit (GE healthcare),
concentrated by precipitation with acetone (Sigma, St. Louis, MI),
and the protein pellet was resuspended at a protein concentration
of 2.5 mg/mL in standard cell lysis buffer (UTC buffer) containing
8 M urea, 2 M thiourea, 4% (w/v) CHAPS and 30 mM Tris,
adjusted to pH 8.5 as previously described [30]. Sample quality
and protein amount was checked by loading 10 mg of each sample
onto a 10% SDS-PAGE precast gel (Bio-Rad) stained with
ImperialTM Protein Stain solution (Fisher Scientific) (data not
shown). Proteins in each sample were minimally labeled with
CyDye according to the manufacturer’s recommended protocols
and as previously described [25]. Briefly, 50 mg of each protein
sample were labeled with 400 pmol of either Cy3 or Cy5, freshly
dissolved in anhydrous dimethylformamide, and incubated on ice
for 30 min in the dark. The reaction was quenched with 1 mL of
10 mM free lysine by incubation 10 min on ice in the dark. An
internal standard pool was generated for each study by combining
an equal amount (25 mg) of each sample included in the study and
was labeled with Cy-2. Cy3-, Cy5- and Cy2-labeled samples were
then pooled (Tables S1 and S2), and an equal volume of UTC
buffer containing 10 mM DTT and 1% (v/v) immobilized pH
gradient (IPG) buffer corresponding to the IPG strips used, was
added.
Two-dimensional Electrophoresis
For the first dimension, labelled-samples were separated by
isoelectric focusing (IEF) with precast 18-cm IPG strips with
different pH gradient ranges (3–10 L, 4–7 or 6–11), rehydrated for
6 hours with DeStreak rehydration solution containing 1% (v/v)
IPG buffer (pH 3–10 L, 4–7 or 6–11). The samples were applied
at the acidic end of the IPG strips using a cup-loading technique.
IEF was carried out at 20uC for a total of 55 kVh on an Ettan
IPGphor 3 electrophoresis unit (GE Healthcare). Prior to
separation in the second dimension, the IPG strips were reduced
in Equilibration buffer (50 mM Tris-HCl, pH 8.6 buffer, 6 M
urea, 2% SDS and 30% glycerol) supplemented with 1% (w/v)
DTT for 10 min and then alkylated in Equilibration buffer
containing 2.5% (w/v) iodoacetamide for 10 min. Equilibrated
IPG strips were then deposed onto 10% SDS-PAGE gels using
Ettan DALT six system (GE Healthcare UK). Strips were overlaid
with 0.5% low-melting point agarose in 16 running buffer
containing bromophenol blue and electrophoresis was run
overnight at 20uC, 1.5 W/gel, until the dye reached the bottom
of the gel.
Image Analysis
After electrophoresis, the gels with Cydye-labeled proteins were
scanned three times with a TyphoonTM Trio Image scanner (GE
Healthcare UK) each time at different excitation wavelengths
(Cy3, 580 BP 30/green (532 nm); Cy5, 670 BP 30/red (633 nm);
Cy2, 520 BP 40/blue (488)). Pre-scans were performed to adjust
the photomultiplier tube (PMT) voltage to obtain images with a
maximum intensity of 60 000 to 80 000 U. Images were cropped
with ImageQuantTM software (GE Healthcare UK) and further
analyzed using the software package Progenesis SameSpot v2
software (Nonlinear Dynamics, Newcastle upon Tyne, UK). The
gel images were aligned by automated calculation of alignment
vectors after assigning landmark vectors. Background subtraction
and spot intensity normalization were automatically performed by
Progenesis SameSpots. Protein spots which presented a significant
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abundance variation between the 3 experimental groups (|ratio|
$1.3, ANOVA p#0.05) were marked and submitted to mass
spectrometry for identification.
In-gel Digestion
Based on the Progenesis SameSpot analysis, protein spots of
interest from gels stained with ImperialTM Protein Stain solution
were excised and digested using a Shimadzu Xcise automated gel
processing platform (Shimadzu Biotech, Kyoto, Japan) as
described previously [31] and stored at 220uC until their analysis
by mass spectrometry (MS).
Mass Spectrometry Analysis of Peptide Mixture from Gel
Elution and MS Data Analysis
The samples were subjected to nanoscale capillary liquid
chromatography-tandem mass spectrometry (nano LC-MS/MS)
analysis with a QTOF apparatus (Q-TOF Ultima, Waters, MA) as
previously described [25]. The peak lists generated in the
micromass pkl format, were then fed into a local search engine
Mascot Daemon v2.2.2 (Matrix Science, London, UK) against a
mixed Mus musculus and West-Nile virus homemade protein
database (SwissProt). Search parameters were set in order to allow
one missed tryptic cleavage site, the carbamidomethylation of
cysteine, and the possible oxidation of methionine; precursor and
product ion mass error tolerance was ,0.2 Da. All identified
proteins have a Mascot score greater than 34 (Mixed: Mus musculus
and West-Nile virus, 16414 sequences June 26th, 2012), corre-
sponding to a statistically significant (p,0.05) confident identifi-
cation. Moreover, among the positive matches, only protein
identifications based on at least two different non-overlapping
peptide sequences with a mass tolerance ,0.05 Da were accepted.
For single peptide-based identification, in addition to Mascot score
significance, only peptide sequence with at least six consecutive
amino acids detected on MS spectra were considered. These
additional validation criteria struck a balance that limited the
number of false positive matches without missing real proteins of
interest.
iTRAQ Labeling
For iTRAQ labeling, sample pool of each experimental group
was generated by mixing an equal amount of each sample per
group (control, pool-C; early, pool-E; and late, pool-L). Six mice
per group were pooled. Each pool was divided either in four
(control, pool-C1-C4) or 2 (pool-E1-E2 and pool-L1-L2) replicates
containing 100 mg protein. Proteins were precipitated with cold
acetone for 2 h at –20uC, centrifuged for 15 min at 16 0006 g,
dissolved in 20 mL of Dissolution buffer, denatured, reduced,
alkylated and digested with 10 mg of trypsin overnight at 37uC,
following manufacturer’s protocol (iTRAQH Reagent Multiplex
Buffer kit, Applied Biosystems, Foster City, CA, USA) and as
previously described [32]. The resulting peptides were labeled with
iTRAQ reagents (iTRAQH Reagent-8Plex multiplex kit, Applied
Biosystems) according to manufacturer’s instructions. Peptides
from the 4 mock samples (pool-C1-C4) were labeled with 113 to
116 iTRAQ reagents, peptides from the 2 early WNV-infected
samples (pool-E1-E2) were labeled with 117 and 118 iTRAQ
reagents and peptides from the 2 late WNV-infected samples
(pool-L1-L2) were labeled with 119 and 121 iTRAQ reagents
(Table S3) at room temperature for 2 h and stored at 220uC.
Before combining the samples, a pre-mix containing an aliquot of
each sample, cleaned-up using a ZipTipH, was analyzed by MS/
MS to check for peptide labeling efficiency with iTRAQ reagents
and homogeneity of labeling between each sample. The content of
each iTRAQ reagent-labeled sample was then pooled into one
tube according to this previous test. The mixture was then cleaned
using an exchange chromatography (SCX/ICAT cation exchange
cartridge, AB Sciex, Foster City, USA) and reverse-phase
chromatography C18 cartridge (C18 SpinTips, Protea bio, Nıˆmes,
France) prior to separation using an off-gel system (Agilent 3100
OFFGEL fractionator, Agilent Technologies).
Off-gel Separation
The resulting peptides were dried and separated into 12
fractions in-solution with an Agilent 3100 OFFGEL fractionator
(Agilent Technologies). Peptides separation was based on their
isoelectric point on a 13-cm IPG strips pH 3–10 using IPG buffer,
pH 3–10 (Agilent Technologies). The IPG strips and paper wicks
were rehydrated with 40 ml of 2.44% glycerol (v/v), 1% IPG buffer
for 15 min. While the strips were rehydrating, the sample was
solubilized in 1.8 ml of the same rehydration buffer. After
complete rehydration, 150 ml of sample was added to each well,
the wells were sealed, and mineral oil was added to each end of the
strip. The strips were focused until 20 kV h was reached with a
max voltage of 8000 V, 50 mA, 200 mW, and a hold setting of
500 V. After 24 h of running time the paper wicks were changed
with new wicks wetted with water. The runs took approximately
35–40 h.
Mass Spectrometry Analysis of Peptide Fractions from
Off-gel Separation
For nanoLC mass spectrometry measurements, approximately
5 mg of peptide sample was injected onto a nanoliquid chroma-
tography system (UltiMateH 3000 Rapid Separation LC (RSLC)
systems, Dionex, Sunnyvale, CA). After pre-concentration and
washing of the sample on a Dionex Acclaim PepMap 100 C18
column (2 cm 6 100 mm internal diameter (id) 100 A, 5 mm
particle size), peptides were separated on a Dionex Acclaim
PepMap RSLC C18 column (15 cm 6 75 mm id, 100 A, 2 mm
particle size) (Dionex, Amsterdam) using a linear 180 min gradient
(4–40% acetonitrile/H20; 0.1% formic acid) at a flow rate of
300 nL/min. The separation of the peptides was monitored by a
UV detector (absorption at 214 nm). The nanoLC was coupled to
a nanospray source of a linear ion trap Orbitrap mass
spectrometer (LTQ Velos Orbitrap, Thermo Electron, Bremen,
Germany). The LTQ spray voltage was 1.4 kV and the capillary
temperature was set at 275uC. All samples were measured in a
data dependent acquisition mode. Each run was preceded by a
blank MS run in order to monitor system background. The
peptide masses were measured in a survey full scan (scan range
300–1700 m/z, with 30 K FWHM resolution at m/z = 400, target
AGC value of 106 ions and maximum injection time of 500 ms). In
parallel to the high-resolution full scan in the Orbitrap, the data-
dependent HCD scans of the 10 most intense precursor ions were
fragmented and measured in the orbitrap analyser (normalized
collision energy of 35%, activation time of 10 ms target AGC
value of 104, maximum injection time 100 ms, isolation window
2 Da and wideband activation enabled). Dynamic exclusion was
implemented with a repeat count of 1 and exclusion duration of
30 sec.
Data Analysis
Raw files generated from mass spectrometry analysis were
combined and processed with Proteome Discoverer 1.3 (Thermo
Fisher Scientific). This software was used for extraction of MGF
files. Protein identification and quantification were carried out
using ProteinPilot version 4.0 (Applied Biosytems). The search was
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performed against the mixed database containing 56478 sequences
(Mus musculus (54080 sequences from Uniprot December 13rd,
2011)+West Nile virus (2242 sequences), and some classical
contaminant proteins (156 sequences)). Data were processed as
described previously [33].
SDS-PAGE, Blotting, and Analysis Procedures
Immunoblotting with fluorescence-based methods was used to
detect both the total protein expression profile and the specific
immunoreactive proteins, as described previously [25]. The same
protein samples used for proteomic analysis were minimally
labeled with CyDye (i.e., Cy3) as described above (see ‘‘CyDye
Labeling’’ section). Labeled samples were separated by 10% or 4–
20% SDS-PAGE in a Mini-PROTEAN Cell (Bio-Rad) according
to the molecular weight of the targeted proteins. Gels were
transferred to a nitrocellulose membrane (0.45 mm; GE Health-
care) using a semidry blotting system at 200 mA for 30 min (TE
77 PWR Semi-Dry Transfer Unit, GE Healthcare) [34]. Blots
were saturated with 5% nonfat dried milk in PBS containing
0.05% (v/v) Tween 20 (PBS-T-milk) for 1 h. Western blot (WB)
analyses were carried out with rabbit mono- or polyclonal
antibodies directed against microtubule-associated protein 2
(1:400, MAP2, no. sc-20172, Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA), microtubule-associated protein 1B (1:400,
MAP1B, no. sc-25729, Santa Cruz), clathrin heavy chain (1:500,
CLTC, no. 2410, Cell Signaling Technology, Danvers, MA),
dynamin 1 (1:1000, DNM1, no. sc-6402, Santa Cruz), vimentin
(1:500, VIM, no. 3932, Cell Signaling), E3 ubiquitin-protein ligase
HUWE1 (1:200, UREB1, no. sc-134821, Santa Cruz), signal
transducer and activator of transcription 1 (1:1000, STAT1, no.
9172, Cell Signaling), phosphotyrosine701-STAT1 (1:500, phos-
pho-STAT1 (Tyr701), no. 9167, Cell Signaling), STAT2 (1:100,
STAT2, no. sc-22816, Santa Cruz), peroxiredoxin 6 (1:100,
PRDX6, no. sc-134478, Santa Cruz), glial fibrillary acidic protein
(1:1000, GFAP, no. Z0334, DAKO, Glostrup, Denmark), or with
a goat polyclonal antibody directed against calpain 9 (1:400,
CAPN9, no. sc-66508, Santa Cruz), diluted in PBS-T-milk and
incubated overnight at 4uC. After three washes in PBS-T, primary
rabbit antibodies were revealed with ECL Plex goat anti-rabbit
IgG Cy5-conjugated secondary antibody (1:1000, GE Healthcare),
and rabbit anti-goat IgG fluorescein isothiocyanate (FITC)
conjugate (1:400, Southern Biotech, Birmingham, AL) was used
for the detection of anti-CAPN9 goat antibody diluted in PBS-T-
milk. All manipulations were protected from light. As a positive
control for the p-701-STAT1 antibody response, a lysate of
murine bone marrow-derived macrophages stimulated for two
hours with IFN-c (PeproTech; 20 ng/ml) was used. The gels
electrophoresis and immunoblots were scanned using a Typhoon
Trio image scanner as mentioned above (see ‘‘Image Analysis’’
section). Immunoreactive bands were analyzed using TotalLab
Quant v12.2 software (Nonlinear Dynamics). To evaluate the
expression level of the different proteins, immunoreactive band
intensities were normalized to the intensities of a global protein
pattern labeled with Cy3 as described previously [25]. Band
intensities were also corrected for the adjacent background.
Differences in the relative abundance of each protein between
two independent groups were determined using Student’s t-test.
All differences were considered significant at p,0.05 and statistical
analysis was performed using GraphPad Prism v5.01 statistical
software (GraphPad Software Inc., La Jolla, CA). Standard
molecular weight markers were loaded in each gel (Bio-Rad).
Ingenuity Pathway Analysis
A dataset containing differentially regulated proteins obtained
from the 2D-DIGE and iTRAQ analysis and their corresponding
expression values (fold-change and p-values) were uploaded into
the IPA software, Inc. (http://www.ingenuity.com). In this
analysis, the evolution of protein expression was taken into
account according to the onset of clinical symptoms. Proteins
whose expression was significantly differentially regulated (fold-
change $1.3, p-value # 0.05) were selected for the analysis. The
IPA program uses a knowledgebase (IPA KB) derived from the
scientific literature to connect genes or proteins based on their
relationships and functions. Ingenuity Pathway Analysis generates
biological networks, canonical pathways and functions that are
relevant to the uploaded dataset. A right-tailed Fisher’s exact test is
used for calculating p-values to determine if the probability that
the association between the proteins in the dataset and the
functional and canonical pathway can be explained by chance
alone. The scores are derived from a p-value (score =2log (p-
value)) and indicate the likelihood that the proteins of interest (i.e.,
the identified proteins within a network)) are clustered together.
Thus, these proteins and their association with the IPA KB were
used to generate networks and to perform functional canonical
pathway analyses.
Results
Virus Kinetics Study
To determine the time-point at which the virus is first detected
in the brain after peripheral inoculation (i.e., early time-point,
WNV-E) and the time-point of advanced disease (i.e., late time-
point, WNV-L) for the collection of brain samples, a kinetics
experiment was carried out in which mice were infected and
subsequently euthanized on day 3, 4, 5 and 6. On day 3, mice did
not yet display clinical symptoms, but on day 4 after infection,
mice first started to show signs of illness such as lethargy, decreased
mobility and balancing problems, and by day 6 they displayed
signs of immobility and paralysis. Virus titers in the brains of these
mice were determined by qRT-PCR and infection was confirmed
at all four time-points (Figure 1A). On day 3, approximately 6.5
log10 of positive strand RNA copies were present in the brain,
which steadily increased until day 6 to approximately 9 log10 RNA
copies. Based on these results, we determined the early time-point
of infection to be on day 3 and the late time-point to be on day 5.
All mice euthanized at the early and late time-point were positive
for virus in the brain with mean virus titers of approximately 5.3
log10 and 8.7 log10 positive strand RNA copies, respectively
(Figure 1B). All control mice were negative for virus in the brain.
Infection of the brain was also confirmed using immunohisto-
chemical staining with an anti-WNV-NS3 polyclonal antibody.
Viral antigen was not detected in brain samples collected on day 1
or 2 after infection. In contrast, low amount of virus was
demonstrated in the brains of mice at the early time-point
(Figure 1C), whereas more extensive staining was found at the late
time-point (Figure 1D), in line with the PCR results. It cannot be
excluded that the viral RNA detected in the brain contained spill-
over virus from the blood. However, the aim of the RT-PCR was
to confirm that presence of viral antigen was associated with
presence of viral RNA.
Detection of Differentially Expressed Proteins Following
WNV Infection by 2D-DIGE Analysis
To determine the proteins that were differentially regulated
following WNV infection, half whole brain hemispheres from
WNV-infected mice were sampled at early (E) and late (L) time-
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points, and protein extracts were analyzed by 2D-DIGE (Tables
S1 and S2). Brains from non-infected mice (mock) were used as
controls. Six mice per group were tested.
Using the Progenesis SameSpot v.2 software, the abundance of
37 protein spots was found to be significantly changed (ANOVA,
p#0.05) between the three groups (mock, WNV-E and WNV-L)
with a fold-change $30% (|FC| $1.3) in the pH range 3–10
(Figure 2A). The major portion of the protein spots were
significantly altered at the late time-point compared to both the
mock condition (85%, n = 32; 25 up- and 7 down-regulated,
Figure 2D) and the early-groups (81%, n = 34; 25 up- and 9 down-
regulated, Figure 2C). The comparison of protein profiles between
the early- and mock-groups allowed the detection of six protein
spots representing significant changes (4 up- and 2 down-
regulated, Figure 2B). Because the determination of host proteome
alterations prior to the appearance of clinical symptoms after
WNV infection was one of the main aims of the present study, 2D-
DIGE analyses were performed on early-infected samples com-
pared to mock-infected samples using narrower pH range IPG
strips (pH 4–7 and 6–11) to enhance and increase protein
resolution. Using pH 4–7 IPG strips for the IEF, 19 protein spots
were found to be significantly altered between early WNV- and
mock-infected samples (fold-change $1.3, p#0.05) (14 up- and 5
down-regulated, Figure S1). Although no protein spots were found
to be significantly differentially regulated using pH 6–11 IPG
strips (data not shown), the use of a narrower pH range allowed a
Figure 1. Detection of WNV in brains of mice infected with WNV-NY99. (A) The amount of WNV positive-sense RNA copies present in the
brains of mice between days 3 and 6 post-infection with WNV-NY99. Mice were euthanized on day 3, 4, 5 and 6 post-infection and brains were
collected and homogenized in DMEM for RNA isolation. (B) The amount of positive-sense RNA copies present in the brains of control mice and mice
inoculated on days 3 and 5 post-infection. Brains were collected in RNA-later for RNA isolation using Trizol. Histopathology of the brains of 9-day old
C57BL/6 mice infected with WNV-NY99. (C) Infected neurons in the brain of a mouse euthanized on day 3 p.i. (objective 20x). (D) Infected neurons in
the cortex of a mouse euthanized on day 5 p.i. (objective 20x). Pictures are representative of the number of infected cells found in the brain for the
majority of mice.
doi:10.1371/journal.pone.0068318.g001
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three-fold increase in the number of differentially regulated
protein spots at the early time-point compared to the mock
group. Overall, a total of 56 distinct protein spots were found to be
differentially regulated in the brain following WNV infection.
Identification of Altered Protein Abundance Following
WNV Infection from 2D-DIGE Analysis
The 56 protein spots of interest were excised from gels,
subjected to in-gel digestion, and then analyzed by tandem MS for
identification. The resulting fragment ion spectra were searched
against Mus musculus and West Nile virus protein databases
(SwissProt). Among the 37 protein spots selected from the 3–
10 pH range analysis, 34 (91.9%) were successfully identified with
a high degree of confidence, corresponding to 25 distinct proteins
according to their accession number (Table 1). These proteins
were grouped into functional categories according to gene
ontology (GO). Multiple proteins were present in some of these
spots; one spot contained a mixture of viral and human proteins
(e.g., spot ID: 710), and some proteins were present in multiple
spots (e.g., Dynamin-1 was detected in spot IDs: 475 and 476 in the
pH range 3–10, Figure 2A and Table 1). As expected, the most
important average fold-change corresponded to WNV proteins
(mean 6 SD: 3.861.8, Table 1). Interestingly, despite a detection
of viral RNA in the brain of all animals prior to and after clinical
onset (Figure 1), viral proteins were identified only at the late time-
point, indicating that at the early time-point, viral proteins are
below the detection limit of this method. Three protein spots could
not be identified, most likely due to an insufficient amount of
protein and/or low MS spectra quality.
Among the 19 protein spots selected from the 4–7 pH range
analysis, 17 (89.5%) were identified corresponding to 10 distinct
host proteins according to their SwissProt accession number
(Table S4), and four of them were identified in more than one
spot. As observed using the pH 3–10 analysis, at the early time-
point, no viral proteins were identified. Among the five proteins
identified at WNV-E with the pH 3–10 analysis, three proteins
(serum albumin, dynamin 1 and T-complex protein 1 subunit
gamma) were also characterized with the pH 4–7 analysis at the
early time-point and were differentially regulated in the same way.
Thus, a total of 12 distinct differentially regulated proteins were
identified in the WNV-E samples before the appearance of clinical
symptoms. Taking into account both pH ranges of the 2D-DIGE
analyses, 30 unique significantly differentially regulated host
proteins were identified. Of these proteins, some (ACTB, ALBU,
DYN1 and HSP7C) were found to be commonly regulated
between the different comparisons, and others appeared to be
differentially regulated exclusively at the early or late time-points,
as depicted in the Venn diagram (Figure 3A).
Identification of Differentially Expressed Proteins
Following WNV Infection using iTRAQ Labeling
To complete the overview of mouse brain proteome changes
after WNV infection, an off-gel quantitative proteomic analysis
was performed using iTRAQ reagents allowing the labeling and
the comparison of 8 distinct samples. Then, the six brain samples
from each experimental condition (i.e., WNV-E, WNV-L and
mock) were pooled and separated into four mock, two WNV-E
and two WNV-L replicates, each labeled with a specific iTRAQ
reagent (from 113 to 121 as indicated in Table S3). Labeled
samples were mixed and separated by an off-gel system into 12
fractions prior to subjecting each fraction to tandem MS analysis.
Data generated were analyzed with Protein Pilot software using
the parameters described above. The application of a global False
Discovery Rate (FDR) of 5% and the exclusion of classical
contaminant proteins gave rise to a total of 1159 identified and
quantified proteins that were included in the analysis.
Among them, a total of 124 distinct proteins were found to be
modified (p#0.05) between the three groups (mock, early and late)
with a fold-change $30% (|FC| $1.3) (Table S5). Among them,
83 proteins were changed between WNV-E and mock-infected
mice (47 up- and 36 down-regulated). Between the WNV-L and
mock-infected mice, 83 proteins were found to be modified (62 up-
and 21 down-regulated), and between the WNV-L and WNV-E
time-points, 46 proteins was found to be modified (31 up- and 15
down-regulated). Among the 124 differentially regulated proteins,
13 were found commonly modified in the three comparisons, and
62 proteins showed modified expression in paired comparisons
(Figure 3B). Additionally, 49 proteins were differentially regulated
in only one comparison: 17 between the WNV-E and mock-
infected mice, 24 between the WNV-L and mock-infected mice,
and 8 between the WNV-L and WNV-E time-points.
Combination of In-gel (2D-DIGE) and Off-gel (iTRAQ-
labeling) Analyses
The two complementary quantitative proteomic approaches,
2D-DIGE and iTRAQ labeling, generated a total of 148 unique
host proteins that were found to be differentially expressed in brain
tissue samples after WNV infection at the early and/or late time-
points. Six proteins (TRE, ALBU, DNM1, GFAP, TCPG and
DPYSL2) were identified by both proteomic approaches and were
differentially regulated in the same way. The cellular distribution
analysis and functional annotation of these significantly differen-
tially expressed proteins was performed (Figure 3C and 3D).
To obtain a better view of the expression profile of these
differentially regulated proteins during the course of WNV
infection, a cluster analysis was performed. Using a hierarchical
clustering analysis, proteins that showed the same expression
patterns during the WNV infection were grouped together
(Figure 3E). Five clusters of expression pattern could be
distinguished. Cluster 1 contains 36 proteins that are mainly
repressed at the early and/or late time-points. Many of these
proteins were involved in nervous system development, (e.g., APP,
MAP1B, MAP2, NCAM1 and DPYSL proteins), and transcrip-
tion/translation regulation (e.g., PELP1, EEF2 and RPS15A).
Cluster 2 encompassed proteins whose expression was down-
regulated at the early time-point and was subsequently unchanged
or up-regulated compared to the earliest time-points. This cluster
was composed of 25 proteins involved in transport and transcrip-
Figure 2. 2D-DIGE analysis (pH 3–10) of mock-, early and late WNV-infected brain samples. (A) Representative data from a 2D-DIGE
experiment using a 10% SDS-polyacrylamide gel with the pH range from 3 to 10 are shown. Proteins from mock- and late WNV-infected brain
samples were labeled with Cy5 and Cy3 cyanine dyes, respectively. As determined by Progenesis SameSpot software, protein spots that were
differentially regulated between the three experimental conditions (|ratio|$1.3 and p#0.05), were submitted to mass spectrometry for identification.
The numbers annotated on the gel correspond to master gel numbers of differentially regulated protein spots. Spots identified as Mus musculus
(numbers#) and WNV (numbers*) proteins are listed in Table 1. Spots identified as a mixture of both species are indicated by numbers#*. Spots that
were differentially modified between WNV-early and mock (B), WNV-late and WNV-early (C) and WNV-late and mock (D) infected samples are
represented by red (up-regulated) or blue (down-regulated) dots.
doi:10.1371/journal.pone.0068318.g002
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tion/translation regulation. Clusters 3, 4 and 5 included 22, 18
and 47 proteins, respectively, that were up-regulated in at least one
comparison. Proteins in cluster 3 were mainly associated with
transport, proteins in cluster 4 were related to host response and
proteins in cluster 5 were associated with protein modifications
(e.g., CCT proteins, HSP90 and UBE2M), metabolic process (e.g.,
ALDH2, PGK1) and transcriptional regulation (e.g., STAT1 and
STAT2).
Interestingly, most of the 55 proteins that were found to be
differentially regulated at the early and late time-points compared
to mock were modified in the same direction (12 down- and 32 up-
regulated proteins). Some of them showed an amplification of the
differential regulation during the time-course of WNV-infection
(early vs. mock and late vs. early), such as PPID and PCM1 (down-
regulated) and TAPBP and STAT1 (up-regulated). The other 11
proteins were differentially regulated in opposing ways at the early
and late time-points (Figure 3E, Tables 1 and 2, Table S5).
Differentially regulated proteins and their respective biological
functions and processes were further analyzed using bioinformatics
to predict the possible effects of their altered abundance.
Networks, Biological Pathways and Functions Involved in
the Clinical Evolution of WNV Infection at the Brain Level
To understand and highlight the relationship of these differen-
tially regulated proteins and the consequences of these modifica-
tions in the context of their cellular function, during the course of
WNV infection in the brain, before and after the appearance of
clinical symptoms, a bioinformatics analysis using a web-based
entry tool developed by Ingenuity Systems, Inc. (http//www.
ingenuity.com) was performed. The 148 unique significantly
differentially regulated host proteins were uploaded into IPA to
statistically determine the functions and pathways that were most
strongly associated with the protein list and to establish
interactions with other proteins in known networks.
At the early time-point after WNV-infection compared to the
mock-group, the mapping of our protein dataset (n = 93) onto
biological pathways and disease networks allowed us to identify a
total of five relevant networks. Three of these top networks were
represented with more than 20 focus molecules involved in
functions related to protein synthesis and cell death (network 1),
nervous system development and cell morphology (network 2),
molecular transport and cell cycle (network 3) (Table 2). Among
the 23 differentially regulated proteins from network 1, five
proteins (HSP70, HSP90AB1, HSPA8, SUGT1, UBE2V1) that
are associated with the ubiquitination pathway were found to be
mainly down-regulated, and some of them are linked to the down-
regulated ubiquitin-like SUMO3 (Figure S2A). In contrast, an
increase of STAT1 and STAT2, proteins that are known to be
involved in the activation of the innate antiviral responses of the
host, particularly the type I interferon response (e.g., IFN-a, IFN-
b), was observed. The differential regulation of these groups of
proteins, which have critical roles in many cellular processes, is
particularly interesting. Although 198 canonical pathways could
be generated at the WNV-E time-point, 30 of them presented a
significant association (2Log (p-value).2.0), as indicated in Table
S6. The most relevant pathways were related to entry and exit of
the virus including clathrin/caveolar-mediated endocytosis but
also to mediators of cytoskeleton organization (Rho protein family
and actin cytoskeleton signaling), cell-to-cell interactions (Integrins,
FAK signaling), and the protein ubiquitination pathway. In
addition, biological functions related to these proteins, ranked by
significance, corresponded to cellular assembly and organization
(p-value: 9.69E-07), cellular function and maintenance (p-value:
9.27E-06), and cellular development (p-value: 5.90E-05). In terms
of diseases and disorders, in addition to 37 molecules associated
with neurological disease, which had the strongest p-values (2.66E-
06), 22 proteins were also significantly associated with inflamma-
tory disease and host response (p-value: 1.01E-05), including
mostly up-regulated proteins such as ACT, DCTN, DNM1,
GFAP and STAT1. Collectively, this analysis indicated an
important effect of WNV-infection at the early time-point on (i)
host response via down-regulation of ubiquitination-related
proteins, (ii) on virus entry via up-regulation of clathrin-mediated
endocytosis and (iii) on cell morphology/cytoskeleton network.
At the late-time-point after WNV infection compared to the
mock group, the use of IPA identified relationships among the 96
modified proteins and generated a total of five networks. The top
three networks contained at least 19 focus molecules that have
functions related to cellular assembly and organization, nervous
system development, cell death (network 1); cell death and
neurological diseases (network 2); and molecular transport and
cellular function and maintenance (network 3) (Table 2). Among
the most significant biological functions determined by IPA, cell
death (p-value: 6.95E-11) was the first that was identified and
included 52 out of the 96 proteins (54%) that are differentially
regulated between the late and mock-infected samples. To provide
a greater degree of molecular detail from this biological function, a
sub-network of interactions between cell death-related proteins
was built de novo using IPA (Figure S2B). This sub-network showed
that 73% of these proteins with a cell death function interact
directly or indirectly with each other. Among them, the down-
regulated APP protein seems to play a central role in this network
and interact with several of the differentially regulated proteins.
The abundance variation of APP following virus infections has
been recently reported [35]. In addition, 30 molecules were found
to be significantly associated with inflammatory disease and
response (p-value: 6.97E-11), and several of them were associated
with the cell death sub-network. In addition to their association
with inflammation, the analysis revealed that most of these ‘‘cell
death’’ proteins were also related to neurological disorders.
Interestingly, 22 of the proteins from the cell death sub-network
were not found to be differentially regulated at the early time-
point, suggesting that the clinical onset could be linked to CNS cell
degradation. Between the late and mock-infected samples, 236
Figure 3. Classification of proteins significantly differentially regulated following WNV infection identified by 2D-DIGE and iTRAQ
analysis. Venn diagram representing unique host proteins identified according to experimental group comparisons following WNV-infection by 2D-
DIGE (A) and iTRAQ (B) analysis. The number of host proteins significantly differentially regulated between WNV-E and mock, WNV-L and mock or
WNV-L and WNV-E are indicated. The two samples that were compared are indicated adjacent to each circle. The number and the percentage of
proteins associated with each category are indicated in brackets. Classification of the significantly differentially regulated proteins according to their
sub-cellular location (C) and their functional categorization (D) according to gene ontology. The percentages of proteins associated with each
category are indicated in brackets. (E) Hierarchical clustering analysis was performed according to the (mean) ratios calculated between WNV-E and
mock, WNV-L and mock or WNV-L and WNV-E, as indicated at the top of the graphic. Up- and down-regulated proteins are shown in red and green,
respectively, and proteins with no change in expression level are indicated in black. The intensity of red or green color corresponds to the degree of
regulation as indicated by the color strip at the bottom of the figure in arbitrary units. The graphical cluster was generated using the Genesis program
[130].
doi:10.1371/journal.pone.0068318.g003
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Table 2. Top three IPA-generated networks of differentially expressed molecules identified by DIGE and iTRAQ labeling between
early and mock, late and mock, and late and early WNV-infected brain samples.
Top Functions Score
Focus
Molecules Molecules in Network
Early vs mock
Protein Synthesis,
Cell Death, Cancer
49 23 up-regulated
ACO2 (includes EG:11429), GFAP, HNRNPA2B1, HP, HSP90AB1, METAP2, PGK1, PRUNE, STAT1,
STAT2, TAPBP
down-regulated
ALB, ARL8B, ATP5B, CAMK4, CSNK2A1, HBB, HSPA8, PPID, RNA RPS21, SUGT1, SUMO3, UBE2V1
not in the dataset
Creb, hemoglobin, Hsp70, Ifi47, ISGF3, IWS1, NLRP12, Nlrp4a, RNA polymerase II, Secretase
gamma, Stat1-Stat2, UBE2F
Nervous System
Development and Function,
Organ Morphology, Cell
Morphology
48 22 up-regulated
ACTA2, ACTB, ACTG2, CCT3, CCT4, CLTC, DCTN1, DNM1, DPYSL2, GAP43, GNAQ, MAP2,
MAP1B, MARCKSL1, NCAM1, SPTAN1, SYN1, TRRAP
down-regulated
CDK5, CYFIP2, EPB42, WASF1
not in the dataset
Actin, Alpha Actinin, Alpha tubulin, Beta Tubulin, Calmodulin, Clathrin, F Actin, G-Actin, Hsp90,
PLC gamma, Profilin, Spectrin, Tubulin
Molecular Transport,
Small Molecule
Biochemistry,
Cell Cycle
43 21 up-regulated
API5, BSG (includes EG:12215), CAPN9, CECR6, GNAO1, Hmgb1 (includes EG:100041307), Hmgb1
(includes EG:25459), HSD17B4, OPCML, PNP, PSMD2, RQCD1, WDR72
down-regulated
CEP290, FBXL16, GANAB, HUWE1, PCM1, PELP1, PSMC3, TANC2
not in the dataset
ATP1B2, BCAS3, HTT, JKAMP, miR-30c-5p (and other miRNAs w/seed GUAAACA), miR-340-5p
(miRNAs w/seed UAUAAAG), NDRG1, PAAF1, PPIC, PRNP, RB1, Serpina3g (includes others),
TP53 (includes EG:22059), UBA5
Late vs mock
Cellular Assembly and
Organization, Nervous
System Development
and Function, Cell Death
48 22 up-regulated
ACO2 (includes EG:11429), ACTB, CAMK2A, CCT3, CCT5, CLTC, DNM1, GNAQ, HSPA8, MBP,
MSN, PPP2R1A, SPTAN1, SPTBN1, STXBP1, SUMO3, SYN1, VIM
down-regulated
DPYSL2, GARS, NAPA (includes EG:108124), TCP1
not in the dataset
Actin, Alpha Actinin, Alpha catenin, Alpha tubulin, Beta Tubulin, Calmodulin, Clathrin,
Dynamin, F Actin, Hsp27, PLC gamma, Spectrin, Tubulin
Cell Death,
Developmental Disorder,
Neurological Disease
42 21 up-regulated
CTNNB1, ENO1, GFAP, GIT1 (includes EG:216963), HBB, HLA-C, PSMD2, PTPRZ1, SOD1,
STAT1, STAT2, TAPBP, TRRAP
down-regulated
APP, CSNK2A1, FASN, LRP1 (includes EG:16971), PELP1, PRKACB, SFPQ, SUGT1
not in the dataset
26s Proteasome, Akt, Cyclin A, Cyclin E, ERK1/2, Focal adhesion kinase, Histone h4, Hsp70,
Hsp90, MHC Class I (complex), MHC Class II (complex), NFkB (complex), RNA polymerase II,
Secretase gamma
Molecular Transport,
Cellular Function and
Maintenance, Nucleic
Acid Metabolism
38 19 up-regulated
ALB, ALDOA, API5, APOA1, ARPC5, ATP1A1, ATP1B1, ATP2B2, ATP5B, CAPN9, HEPACAM, HP,
HPX, METAP2, OPCML, TF, WDR72
down-regulated
Cyfip2, TANC2
not in the dataset
AGT, APOC1, APOF, ATP5, ATP synthase, CACNA1A, calpain, CD163, CHD1L, FXYD2, HDL,
hemoglobin, HTT, miR-340-5p (miRNAs w/seed UAUAAAG), miR-488-3p
(and other miRNAs w/seed UGAAAGG), RBP4
Late vs Early
Cell Morphology,
Cellular Assembly and
Organization, Cellular
Function and Maintenance
40 19 up-regulated
ACTB, ARL8B, CAMK2A, CDK5, CTNNB1, CTTN, DNM1, HSPA8, TUBB, WASF1
down-regulated
APP, CRMP1, DPYSL2, DPYSL3, MAP2, MAP1B, NAPA (includes EG:108124), NCAM1, TCP1
not in the dataset
26s Proteasome, Actin, Beta Tubulin, Calmodulin, Alpha tubulin, CaMKII, CRMP, Dynamin,
F Actin, Focal adhesion kinase, Hsp27, Hsp70, Hsp90, PLC gamma, Secretase gamma, Tubulin
Organismal Injury and
Abnormalities, Respiratory
Disease, Hematological Disease
38 18 up-regulated
AHSG, ALB, CAMK4, CSNK2A1, EEF2, GFAP, HBA1/HBA2, HBB, RPS21, STAT1, SUMO3, TAPBP, TF, UBE2V1,
VIM
down-regulated
GARS, PRKACB, SFPQ
not in the dataset
Akt, APOA4, Cbp/p300, Ceacam1, Creb, DEFB103A/DEFB103B, DEFB4A/DEFB4B, ELP2, HDL, hemoglobin,
Ifi47, IFIT1B, NFkB (complex), RNA polymerase II, SPINK7, Stat1 dimer, UBE2F
Host Response to Severe WNV Infection
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canonical pathways were generated, among which 23 presented a
significant association (2Log (p-value) .2.0, Table S7). The most
relevant pathways were related to entry of the virus including
clathrin/caveolar-mediated endocytosis, as observed at the early
time-point, neurological disorders, and the protein ubiquitination
pathway.
Considering the 65 differentially regulated molecules between
the late and early time-points, the IPA system generated four
networks. The top three networks (Table 2) contained at least 16
focus proteins that have functions related to cell morphology, cell
assembly and organization and cell function and maintenance
(network 1); organismal injury and abnormalities, respiratory
disease, and hematological disease (network 2); and infectious
disease, endocrine system development and function, and energy
production (network 3). The highest scoring network was
composed of 19 proteins from our dataset and mainly contained
up-regulated proteins that are related to cytoskeleton organization,
such as actin, tubulin and dynamin, and down-regulated proteins
that are related to nervous system development, including APP,
DPYSL proteins, MAP1B and MAP2, the latter of which is
associated with neurogenesis and axonogenesis. In addition,
among the most significant functions and diseases listed by IPA,
36 proteins were associated with cell death and 34 with
neurological disease, representing more than half of the proteins.
The analysis also generated 214 canonical pathways among which
16 were highly significant (2Log (p-value) .2.0, Table S8). The
first of these relevant pathways was related to clathrin-mediated
endocytosis, as was observed for the comparisons of the early and
late time-points with the experimental group. These data
highlighted that this pathway appears to be particularly perturbed
during the course of WNV infection. Among the other canonical
pathways that were generated by IPA, several reflect neurological
disorders such as the alteration of proteins involved in amyloid
processing, neuronal semaphorin signaling, cell junction signaling
or synaptic potentiation. Taken together, the analysis of proteins
that are differentially regulated at the late stage of infection
pointed to their involvement, in addition to viral circulation, in
processes that are linked to neurological disorders and nervous
system development impairment, eventually leading to cell death.
Verification of Protein Abundance Variations from
Selected Candidates
To verify the 2D DIGE and iTRAQ results, WB analyses were
performed. Among the 148 differentially regulated proteins
identified, a total of 12 candidates were selected as being
representative of the altered of the cytoskeleton organization
(DNM1, VIM, MAP1B, MAP2, CLTC), the ubiquitination
pathway (HUWE1), the inflammatory response (STAT1 and
phospho-701 STAT1, STAT2, PRDX6) or the nervous system
and the cell death pathway (GFAP, CAPN9), according to the
availability of the corresponding antibodies. For all WB, each
protein sample was labeled with cyanine-3 dye to reveal the
variations in sample loading that were taken into account for the
normalization and the calculation of the average band volume
ratio that was detected by each selected antibody and revealed by
fluorescence-conjugated secondary antibody (FITC or ECL Plex
system). In these conditions, a precise determination of the protein
abundance according to the course of WNV mouse brain infection
was performed.
For proteins that are involved in cytoskeleton organization, the
significant up-regulation of VIM at the late time-point was
confirmed. The transitory increased abundance of microtubule-
associated proteins (MAP2 and MAP1B) at the early time-point
was observed by WB experiments. However, statistical analysis did
not succeed to validate these transitory protein abundance
increases. The lower protein expression variations observed by
WB than those detected by proteomic approaches (Figure 4, Table
S5), and the intra-group variations (i.e., standard deviations)
between the different biological replicates, of protein quantity
measured for some time point, are factors which could alter these
validation steps. Concerning CLTC and DNM1 proteins that
were both found with increased protein abundance during the
time course of WNV infection (Tables 1, S4 and S5), the
confirmation of the significant up-regulation was only successfully
obtained for CLTC (Figure 4). The absence of the significant
variation in the level of DNM1 by WB could be attributed to the
presence of DNM1 isoforms. Effectively, DNM1 is known to
undergo post-translational modifications (i.e., extensive rounds of
phosphorylation and dephosphorylation), leading to several
isoforms with different isoelectric points that are involved in the
activation of the CME pathway [36]. Although the abundance of
several DNM1 protein spots were determined to be altered by 2D-
DIGE (Tables 1 and 2, Figures 2 and S1), it is possible that the
amount of altered and unaltered spots merged in the same 1D
protein band and thus did not significantly affect the total level of
DNM1 protein detected by 1D WB. Complementary experiments
investigating changes in the DNM1 phosphorylation state
according to the host clinical evolution following WNV infection
are necessary to clarify the mechanism of protein regulation. For
proteins that are involved in the protein ubiquitination pathway,
the kinetic down-regulation of HUWE1 during WNV infection, as
determined by iTRAQ analysis, could not be confirmed by WB,
and in contrast a significant protein abundance increase was
detected between late and early time points.
For proteins that are related to the inflammatory response, the
kinetic augmentation of STAT1 protein during WNV infection
(Table S5) was statistically confirmed using a specific antibody.
Conversely, in control samples, these proteins were found at a very
low or undetectable level (Figure 4). Despite the low signal
Table 2. Cont.
Top Functions Score
Focus
Molecules Molecules in Network
Infectious Disease, Endocrine
System Development and
Function, Energy Production
35 16 up-regulated
ATP6V1B2, CAD, CBR1, CNNM3, GANAB, HSDL1, KHSRP, RANBP3, RRAGC, VPS45
down-regulated
CAT, ABCF3, ACOT7, CLCN6, HSD17B4, PCM1
not in the dataset
ACIN1, ATP6AP1, GTF2H4, HADH, HSD17B7, HSD17B10, KHK, LAMTOR1, LAMTOR2, LAMTOR3, MOCS2,
NOA1, PITPNA, PTP4A2, RRAGB, SLC35E1, TMEM173, TOE1, UBC
doi:10.1371/journal.pone.0068318.t002
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detected by WB against STAT2, the increase of STAT2
abundance was confirmed statistically at the early and late time-
points compared to the mock condition. As the phosphorylation of
STAT proteins is required to obtain a functional Jak/STAT
signaling pathway [37], analysis of their phosphorylation states was
performed. Using p-701-STAT1 antibodies, STAT1 phosphory-
lation was detected only in the positive control sample (i.e., murine
macrophages activated with IFN-c). Whereas STAT1 protein
abundance dramatically increases at both time-points compared to
mock, p-701-STAT1 was not detected, suggesting an inhibition of
the Jak/STAT signaling pathway by WNV. Despite the modest
variation of PRDX6 level, the increased abundance of this protein
was significant solely at the late time-point compared to mock, as
determined by 2D-DIGE analysis (Table 1).
For proteins involved in nervous system development and cell
death, the progressive up-regulation of GFAP during the course of
WNV infection was detected by WB, but this protein augmenta-
tion was found statistically significant only at late time point.
Concerning CAPN9, the increase of protein quantity was
statistically confirmed in the late samples.
Figure 4. Western blot validations of differentially regulated proteins identified by 2D-DIGE and/or iTRAQ analyses. (A) Protein
samples from each group used for proteomic analysis were minimally labeled with cyanine-3 dye. At the top, a representative protein profile of three
biological replicates from brain lysates of mock-, and WNV early- and late-infected mice, separated by 10% SDS-PAGE is shown. WB with fluorescence-
based methods was used to detect an overlaid fluorescent scan of the general protein patterns (Cy3 dye (green)) and the specific immunoreactive
proteins (FITC or Cy5 dye (red)). To better visualize protein detection signals observed with each specific antibody used, corresponding cropped WB
images are presented in grey levels. (B) The graphs correspond to the mean 6 S.D. of protein quantity measured by densitometry of the antigenic
bands. Densitometry analyses were performed using TotalLab Quant v12.2 software (Nonlinear Dynamics), and data were normalized to levels of
global protein pattern intensity. The values indicated under each graph correspond to fold changes from paired comparisons (i.e., WNV-E/mock,
WNV-L/mock, WNV-L/WNV-E). WNV-E/2L, biological replicates of brain samples infected by West Nile Virus and collected at early or late time-points.
The significance of the differential protein expression are indicated *, p,0.05; **, p,0.01; ***, p,0.001. A.U., arbitrary units. a-, antibody anti-;w, IFN-
c activated mice bone marrow derived macrophage (p-701-STAT1 positive control); #, no quantification for p-701-STAT1. CAPN9, calpain 9; CLTC,
clathrin heavy chain; DNM1, dynamin 1; GFAP, glial fibrillary acidic protein; HUWE1; E3 ubiquitin-protein ligase; MAP1B, microtubule-associated
protein 1B; MAP2, microtubule-associated protein 2; PRDX6, peroxiredoxin 6; STAT1/2, signal transducer and activator of transcription 1/2; VIM,
vimentin.
doi:10.1371/journal.pone.0068318.g004
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Figure 5. Schematic illustration of key pathways or biological functions altered during the course of WNV infection. Host proteins
that were found to be significantly differentially regulated by proteomic approaches were located in relevant pathways based on the IPA database
results and a careful reading of published literature. The proteins that were determined to be differentially regulated in our study are indicated in the
right portion of each panel, according to the different time-point comparisons. Several functions were altered during the course of WNV-infection in
the mice brain, including: (A) The cytoskeleton remodeling associated with virus circulation as evidenced by the WNV hijacking of the clathrin-
mediated endocytosis pathway (CME) and Rho GTPase signaling. (B) The perturbations of the protein ubiquitination pathway allowing viral proteins
to avoid degradation and/or antigen presentation. (C) The regulation of the JAK/STAT signaling pathway corresponding to an evasion mechanism
against activation of the antiviral response. (D) The kinetic modulation of the inflammatory response leading to brain injuries. (E) Cell death
comprising neuronal necrosis and apoptotic phenomena. (F) The brain damage reflected by the abundance variation of numerous proteins involved
Host Response to Severe WNV Infection
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Collectively, the abundance variations of the majority of the
selected protein candidates were validated by WB while taking into
account the kinetic clinical mouse symptoms (i.e., before and after
the appearance of neurological disorders corresponding to the
early and late time-points). The inability to validate the protein-
level variation for some of these proteins could be attributed to the
presence of unmodified isoforms that could not be distinguished by
1D WB, to the low expression fold-change determined by
proteomic approaches or by the low number of biological
replicates, which may be difficult to confirm despite this rigorous
and original quantitative WB method. Further experiments using
more discriminate quantitative methods, such as selected reaction
monitoring mass spectrometry, would be needed to support some
of these unconfirmed protein abundance variations [38].
Discussion
The current study analyzed the kinetic changes of protein
expression in mouse brain tissue samples that were collected at
early and late time-points post-viral infection, corresponding to the
absence and the appearance of neurological clinical symptoms,
respectively, using comprehensive quantitative proteomic ap-
proaches. A total of 148 unique proteins were found to be
differentially regulated following WNV infection, indicating a
profound host proteome modification at the brain level. The
bioinformatics analysis (Ingenuity Pathway Analysis) of each
protein dataset of the different time-point comparisons revealed
that four major functions were altered during the course of WNV-
infection in the mouse brains: i) modifications of cytoskeleton
maintenance associated with virus circulation; ii) deregulation of
the protein ubiquitination pathway; iii) modulation of the
inflammatory response; and iv) alteration of neurological devel-
opment and neuronal cell death. Networks and pathways that are
associated with differentially regulated proteins are discussed to
characterize the pathophysiologic processes of neuroinvasive
WNV infection at the early and late time-points. Interestingly,
experiments with null mouse models have evidenced the
involvement of the innate and adaptive immune response in
controlling WNV neuroinvasion [39,40,41]. The absence of white
blood cell proteins detection involved in the immune response
could likely attributed to their low abundance compared to brain
proteins, and then were under the detection limit of the present
proteomic approaches. Nevertheless, it seems conceivable that
some of the protein differentially regulated could result from the
presence of immune cells at the neuroinflammatory foci’s.
However, among the proteins differentially regulated, it cannot
be excluded that some protein abundance variations were
attributed to passive phenomena. Complementary experiments
are needed to distinct differentially regulated proteins participating
directly to clinical outcomes from that reflecting virus replication.
i) Modifications of Cytoskeleton Maintenance and Virus
Circulation
Virus entry via clathrin-mediated endocytosis
(CME). As viruses are obligate intracellular pathogens, viral
entry into target cells is necessary to initiate replication and
infection. The use of CME for virus entry has been described for
several viruses, including influenza [42], hepatitis B [43],
orthobunyavirus [44] and WNV [45].
Bioinformatic analysis of our datasets revealed that CME was
one of the most significant canonical pathways generated by IPA,
involving several host proteins that are differentially regulated at
both the early and late time-points. Several key factors participat-
ing in the CME pathway were identified (Figure 5A). Our data
support previous in vitro experiments suggesting that WNV uses
the CME pathway to gain entry into host cells [45]. Clathrin is
recruited for vesicle-coating, dynamin triggers vesicle scission from
parent membrane and heat-shock cognate 70 functions as an
ATPase in clathrin-coat disassembly [46]. Although actin is
dispensable for CME, it could interact with the clathrin network
after recruitment of Arp2/3 to the budding vesicle, which is
mediated by cortactin and neural Wiskott-Aldrich syndrome
protein (N-WASP) [46]. The recruitment of actin polymerization
for CME was reported to provide force for plasma membrane
invagination and vesicle scission [47,48], particularly for the
uptake of large cargoes such as viruses [49]. Taken together, the
up-regulation of these proteins that are required for the CME
pathway supports the use of this pathway by WNV in vivo to gain
host cell entry.
The central role of clathrin function for virus entry into host
cells has been previously documented [50,51]. As WNV entry into
host cells occurs throughout the time-course of infection, the
development of a strategy to block this critical pathway could be a
pertinent approach limiting virus spread prior to and after the
development of clinical events, as was recently shown for dengue
virus replication in vitro [52,53]. As several other members of the
Flaviridae family were also shown to enter cells via CME [54,55],
the inhibition of viral endocytosis via the clathrin pathway could
be applied for the prevention and/or treatment of a wide range of
viral infections [50,56,57].
Actin cytoskeleton remodeling via Rho GTPase
signaling. It appears that the endocytic pathway for WNV is
closely associated with the host cell cytoskeleton network. Indeed,
to optimize viral replication and virion production, actin
cytoskeleton and Rho-family GTPases signaling have been
described to be hijacked by many viruses [58]. In this study, the
abundance of several proteins related to the actin cytoskeleton and
Rho GTPase signaling was found to be modified during the course
of neuroinvasive WNV infection (Figure 5A).
Rho-family GTPases control signal transduction pathways
linking membrane receptors to the cytoskeleton [58]. Rho
GTPases are key regulators of actin and microtubule assembly,
are responsible for cell polarity and adhesion, and play an
important role in neuronal development [58,59]. Among the
proteins participating in the Rho GTPase signaling pathway, the
Arp2/3 complex is a powerful machine for actin filament
formation [60]. This complex is activated by cortactin (CCTN)
and Wiskott-Aldrich syndrome family proteins (WASP) whose
activity is regulated by Rho GTPases such as Cdc42 [61,62]. Rho
GTPases are themselves, under the control of small G proteins
that were found to be up-regulated following WNV infection
(GNAO1 and GNAQ). The augmentation of small G proteins at
in the deterioration of neurological functions. Known partners of identified differentially regulated molecules are indicated. Anti-viral strategies and
potential biomarker candidates associated with the severity of clinical evolution are suggested as indicated in green and blue, respectively. A legend
is shown in the bottom left corner. Abbreviations of IPA-uploaded proteins are listed in Tables 1, S4 and S5. The others are listed as follows: Bax, Bcl2-
associated X protein; BBB, blood-brain barrier; Bcl2, B-cell lymphoma 2; Casp.3, Caspase 3; Cdc42, cell division cycle 42; E1 and E2, ubiquitin-
conjugating enzyme; E3, ubiquitin protein ligase; IFN, interferon; IL, interleukin; IRF9, interferon regulatory factor 9; ISG, interferon-stimulated gene;
ISGF3, IFN stimulated gene factor 3; ISRE, interferon-stimulated response element; JAK1, Janus kinase 1; NS-V, non-structural viral protein; TLR, Toll-
like receptor; TNF-a, tumor necrosis factor alpha; TYK2, tyrosine kinase 2; Ub, ubiquitin.
doi:10.1371/journal.pone.0068318.g005
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the early time-point could trigger Rho GTPase signaling, which
leads to significant actin rearrangements [63].
Interestingly, the initial interaction of herpes virus with the cell
surface could induce Rho GTPase signaling, leading to significant
actin rearrangements [63,64]. This interaction was shown to
facilitate the successful delivery of viral particles into the host cell
cytoplasm. Based on our results and previous studies, we can
hypothesize that after binding of a ligand to the G protein-coupled
receptor, small G proteins are the starting point of cascades of
activation of Rho GTPases such as Cdc42 proteins, leading to the
activation of Arp2/3 by different effectors and thus inducing the
regulation of actin polymerization (Figure 5A). The up-regulation
of numerous proteins involved in these pathways at the early time-
point indicates a strong alteration of the cytoskeleton organization
after WNV infection.
At the late time-point, several of the aforementioned proteins
remained differentially regulated (e.g., ACTB, ARPC5, GNAQ,
GIT1, GFAP and CYFIP2) and an increased level of other
proteins that are involved in cytoskeleton maintenance, such as
myosin (MYO18A), moesin (MSN), spectrin (SPTBN1, SPNA2),
vimentin (VIM) and syntaxin (STXBP1), were detected. These
multifunctional proteins are involved in the regulation of cell
morphology, plasma membrane stability and synaptic vesicles
trafficking [65]. The abundance variation of some of these proteins
has already been shown following other viral infections
[66,67,68,69,70]. Although their exact role following WNV
infection remains to be analyzed in detail, the increased
abundance of these cytoskeletal proteins at the late time-point
may participate in viral particle assembly, cargo and egress leading
to the replication and release of mature virions. Taken together,
these differentially regulated proteins found in our study show that
WNV infection strongly alters the cytoskeleton organization and
dynamics, particularly via Rho GTPase signaling. The role of
molecules from the Rho GTPase signaling pathway in cytoskel-
eton rearrangement has been reported to promote the entry,
replication and spread of many viruses [58], and the inhibition of
Rho GTPase signaling in African Swine Fever Virus (ASFV)-
infected cells has been shown to decrease viral replication [71].
ii) Involvement of Protein Ubiquitination Pathway
Recently, many viruses have been reported to utilize or
manipulate the host ubiquitin-proteasome pathway (UPP) to
escape the cellular immune response, to facilitate virus replication
and to promote virus assembly and budding [72]. We found nine
differentially regulated proteins that are involved in UPP following
WNV-infection. Among them, some proteins were differentially
regulated at both time-points in the same direction (UBE2M,
PSMD2, SUGT1) or in the opposite direction (HSP8, UBE2V1)
or differentially regulated only at one time-point (at the early time-
point: HSP90AB, PSMC3; at the late time-point: HSPA12A,
HLA-C). At the early time-point, the abundance of the
differentially regulated protein from the UPP mainly decreased,
while at the late time-point, an up-regulation of several of these
proteins was observed. The late time-point up-regulation of E2
enzymes (UBE2M and UBE2V1), that are responsible for the
conjugation of ubiquitin to protein substrates, and of MHC class I
proteins (HLA-C) could represent a host response to constrain
viral development by an augmentation of foreign antigen
presentation (Figure 5B). Although the alteration of protein
expression from the UPP seems to be a common phenomenon
following virus infection [72], the use of specific drugs against
proteins from UPP could be an efficient antiviral strategy. UPP
inhibitors target proteasomal functions leading to a complete
inhibition of the ubiquitin pathway [73]. The development of
drugs targeting E ubiquitin-protein ligases, which usually deter-
mine substrate specificity, could inhibit specific ubiquitin-substrate
binding, maintaining the other UPP degradation functions [74].
iii) Activation/Repression of the Inflammatory Response
The activation of interferon type I pathways (e.g., IFN-a, IFN-b)
represents a major antiviral defense mechanism limiting virus
levels, reducing neuronal death, and increasing cell survival [75].
To ensure their survival in the infected host, several viruses have
developed distinct strategies to block the Jak-STAT signaling
pathway, either by inhibiting Jak phosphorylation [76,77], by
inducing the degradation [78], or by blocking the phosphorylation
of STAT1 and/or STAT2 proteins, preventing their nuclear
translocation (Figure 5C) [79]. In the present study, a significant
augmentation of STAT1 and STAT2 protein levels was detected
at the early time-point and was maintained at the late time-point.
The augmentation of STATs proteins could correspond to a host
response following WNV infection, in agreement with previous
findings [80,81]. However, the increase of STAT protein
abundance was not correlated with an increase of STAT
phosphorylation states, as confirmed by WB using a p-701-
STAT-1-specific antibody. Thus, the augmentation of STAT1 and
STAT2 should be linked to the inhibition of STAT phosphory-
lation, blocking their nuclear translocation. Moreover, previous
in vitro studies have reported that non-structural proteins from
WNV can act as IFN antagonists, leading to the inhibition of
STAT1 and STAT2 phosphorylation and their subsequent
translocation to the nucleus [82,83,84]. As blocking IFN signaling
appears to be an obvious strategy for successful virus infection, the
restoration of the Jak-STAT pathway by inhibiting viral protein
binding to IFN receptors or effectors could be a strategy to extend
antiviral therapeutics.
Among other molecules involved in the inflammatory response,
high mobility group box 1 (HMGB1) and peroxiredoxin (PRDX6),
are up-regulated at the early and late time-points, respectively and
have been classified as damage-associated molecular patterns
(DAMPs) [85]. HMGB1 and PRDX6 proteins that are released
from necrotic brain cells are able, respectively, to induce blood
brain barrier (BBB) disruption and bind to macrophage toll-like
receptors (i.e., TLR2 and TLR4), inducing the production of
inflammatory cytokines (i.e., IL1b, TNFa, IL6 and IL23) [86,87].
The production of these cytokines has been described in cell
culture highlighting the strong inflammatory response after WNV
infection that leads to neuronal death [88]. Thus, the increased
expression of HMGB1 and PRDX6 could be effectors of
detrimental inflammation in the brain of WNV-infected mice
and brain injury following WNV infection (Figure 5D).
Interestingly, a delay in the production of HMGB1 and PRDX
in response to brain ischemic stroke was reported with HMGB1
being released prior to PRDX6 [89]. This delayed expression,
which was also observed in the present study, suggests that WNV
infection-induced encephalitis may result from similar inflamma-
tory events as seen in ischemic stroke injury. In addition, the
plasma level of HMGB1 was proposed as a predictive marker of
traumatic brain injury [90] and the disease outcome of dengue
virus infection [91,92]. In addition, the administration of anti-
HMGB1 neutralizing antibodies has been shown to preserve BBB
integrity [93] and suppress the expression of inflammatory
molecules such as TNF-a in the case of brain injury [94]. A
beneficial effect of the use of anti-PRDX antibodies was also
reported, with the reduction of inflammatory cytokines (i.e., IL23
and IL17) [89]. Thus, the investigation of the release of HMGB1
and PRDX6 could be useful to evaluate the degree of brain injury
following WNV infection. Moreover, in the scope of a therapeutic
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strategy, the injection of specific antibodies targeting HMGB1
and/or PRDX6 could have a protective effect against brain
alteration, limiting BBB disruption, and on macrophage recruit-
ment and stimulation [89]. In addition to the inhibition of these
molecules, blocking the receptors (i.e., TLR2, TLR4) or acting on
the downstream cytokines that are produced (i.e., IL23, IL17),
could be alternative ways to reduce the inflammatory response
that is induced by WNV infection [86,87].
iv) Activation of Neuronal Cell Death and Alteration of
the Nervous System
Replication of WNV in the brain has been repeatedly described
to induce neuronal injury, leading to neuronal cell death
[95,96,97]. Here, more than 40% (n = 38) and 55% (n = 53) of
the proteins that are significantly differentially regulated at the
early and late time-points, respectively, compared to the mock-
infected group, were involved in cell death according to IPA,
underlining the large alteration of this biological function during
the course of neuroinvasive WNV.
Among them, at the early time-point, the protein level of
CamK4 and CDK5, two kinases that are involved in the inhibition
of apoptosis, decreased (Figure 5E) [98,99]. To promote its anti-
apoptotic role, CDK5 phosphorylates Bcl2 [100]. However, an
up-regulation of Bax has been reported to be associated with
WNV-induced apoptosis [101]; Bax can bind Bcl2 to suppress its
anti-apoptotic function [102]. Moreover, an inhibition of CamK4
has been shown to induce neuronal cell death [103]; this kinase
can be cleaved by caspase-3 or calpain [104], and the up-
regulation of calpain-9 protein (CAPN9) may then participate in
the decreased protein level of CamK4. Taken together, the
diminution of anti-apoptotic factors (i.e., CDK5 and CamK4) and
the increase of calpain, a pro-apoptotic factor, suggest that the
environment seems favorable for cell death induction following
WNV infection. Nevertheless, the increased abundance of the
apoptotic inhibitor protein 5 (API5), at both time-points, indicates
that the mechanism of cell death regulation is particularly
complex. Effectively, a premature cell death could represent a
host defense mechanism that limits viral replication; in contrast,
intracellular virus replication could also lead to cytopathic effects
and cell death [105]. The up-regulation of anti-apoptosis factors
could enhance the survival of WNV-infected host cells, contrib-
uting to viral persistence and replication. Complementary
experiments would then be needed to determine whether the
differential regulation of proteins involved in cell death corre-
sponds to a host response that is designed to eliminate the virus, or
conversely attributed to virus replication.
WNV infection-induced brain damage is supported in our
in vivo model by the abundance variation of numerous proteins
that have been previously described as markers of central
alteration (Figure 5F).
NCAM-1 predominantly expressed in neurons and glial cells
plays an important role in neuronal development and, in
particular, the formation and the development of axons, dendrites
and synapse plasticity [106]. In this study, NCAM-1 was found to
be up-regulated at the early time-point. NCAMs have been used as
markers for neurological disorders such as multiple sclerosis or
encephalitis [107,108]. To our knowledge, this is the first time that
an alteration of NCAM-1 protein expression was reported
following WNV infection.
GAP43, a marker of axonal growth that is involved in synapse
plasticity, was up-regulated at the early time-point. GAP43
expression was shown to be inversely associated with the intensity
of neuronal injuries in mice (i.e., increased and decreased
expression following moderate and severe brain injury, respec-
tively) [109]. Here, the GAP-43 expression profile suggests that
GAP-43 could activate brain repair mechanisms at the early time-
point, which diminished according to the severity of injuries. As
GAP-43 protein integrity is under the control of calpain [110],
treatment with calpain inhibitors could enhance neuronal repair
mechanisms and neuroprotective effects.
At the late time-point, the abundance of APP, DPYSL2 and
DPYSL3 decreased. APP is a transmembrane glycoprotein that
may have a key role in nervous system development through its
involvement in synapse formation, neuronal migration and
motility [111,112]. APP is a central component of Alzheimer’s
disease (AD), where its cleavage generates b-amyloid peptides. The
decrease in APP abundance at the late stage could be a result of its
proteolysis, leading to an augmentation of b-amyloid peptides.
This hypothesis is in concurrence with a previous proteomic study
performed on WNV-infected neurons that reported an up-
regulation of b-amyloid peptide [26].
DPYSL proteins (or CRMPs) are mediators of the Sema3A
signaling involved in axon and dendrite growth and guidance
[113,114]. Interestingly, DPYSL2 was found to be up-regulated at
the early time-point and further showed a decreased level of
protein abundance at the late time-point together with DPYSL3.
The diminution of DPYSL2 has previously been observed in rat
neurons infected in vitro with WNV using a proteomic approach
[26]. DPYSL proteins can also be cleaved by calpain in
neurological damage [115,116]. Thus, calpain, with its links to
APP, which was located at the center of the sub-network generated
by IPA that was restricted to proteins related to cell death at the
late time-point, appear to be the critical molecules involved in
neuronal death following WNV infection.
The differential regulation of glial- (i.e., GFAP) and oligoden-
drocyte- (i.e., MBP) specific proteins indicated that in vivo WNV
infection affects major brain cell types. GFAP, the main
intermediate filament (IF) protein in mature astrocytes, was found
to be up-regulated during the entire time-course of WNV-infected
mice, and was statistically validated by WB at late time point.
GFAP has been repeatedly mentioned as a reliable biomarker of
brain injury that is released into the CSF and blood [117,118]. In
CSF from patients with WNV meningoencephalitis, an increase of
GFAP was noted; however, the detection of this protein in
individuals presenting only WNV fever underlined that glial brain
degradation could occur in the absence of severe clinical
symptoms [119,120]. Finally, GFAP could represent a biomarker
candidate of brain injury and central virus affect.
Myelin basic protein (MBP) is a major constituent of the myelin
sheath of oligodendrocytes in the CNS, and it has been reported as
both a central (i.e., CSF) and peripheral (i.e., sera) marker of brain
myelinated axonal damage [121]. Elevated serum levels of MBP
have been observed in ischemic stroke [122] and autoimmune
diseases such as multiple sclerosis [123,124], reflecting BBB
disruption and demyelination process. The increased expression
of MBP at the late time-point in our study could correspond to
repair mechanisms following myelin sheath degradation. In vitro
experiments have previously demonstrated that oligodendrocytes
were susceptible to WNV infections [125,126]. Brain demyelin-
ation has been previously reported in humans and rodent models
infected by encephalitic viruses such as HIV [127], Theiler’s
Murine Encephalitis Virus [128], or Japanese encephalitis virus
(JEV) [129]. In JEV-infected mice, the T-cell response against
MBP increased and this autoimmune inflammatory response
seemed to be responsible for axon demyelination [129]. Comple-
mentary experiments could be performed to determine whether
myelin destruction occurred in vivo during WNV-infection and
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whether this myelin degradation may be attributed to an
autoimmune phenotype.
Conclusion
Due to their limited coding capacity, viruses hijack proteins and
pathways of the host to replicate. The combination of compre-
hensive quantitative proteomic approaches with bioinformatics
analysis revealed a wide range of biological processes that were
found to be modified during the time course of WNV infection in
an animal model. Although several of these pathways have been
previously described following WNV infection, our study provides
novel insight into understanding the host response to WNV
infection. The present work unravels crucial virus-host interactions
that take place during a severe neuroinvasive disease, identifies
putative mechanisms involved in WNV pathogenesis, and offers
the description of specific markers of brain cell damage. Finally,
the evolution in protein expression profiles uncovered according to
clinical symptoms could contribute to the development of new
anti-viral therapeutic targets, the identification of additional
biomarkers of disease progression, and eventually could improve
the diagnosis and monitoring of neurological insults to reduce
mortality and neurological sequelae in humans.
Supporting Information
Figure S1 2D-DIGE analysis (pH 4–7) of mock- and
early WNV-infected brain samples. Representative data
from a 2D-DIGE experiment using a 10% SDS-polyacrylamide
gel with the pH range from 4 to 7 are shown. Proteins from mock-
and early- WNV-infected brain samples were labeled with Cy3
and Cy5 cyanine dyes, respectively. As determined by Progenesis
SameSpot software, protein spots that were differentially regulated
between the two experimental conditions (|ratio| $1.3 and
p#0.05) were submitted to mass spectrometry for identification.
The numbers annotated on the gel correspond to master gel
numbers of differentially regulated protein spots. All spots were
identified as Mus musculus and are listed in Table S4. Spots that
were differentially modified between WNV-early and mock (B)
infected samples are represented by red (up-regulated) or blue
(down-regulated) dots.
(TIF)
Figure S2 Most significant protein networks of differ-
entially regulated proteins following WNV infections. (A)
The first significant network of protein differentially regulated
between WNV-E and mock-infected mice. Network 1 that was
associated with ‘‘protein synthesis and cell death’’ was generated
by Ingenuity Pathway Analysis (IPA) software using the list of
differentially expressed proteins at the early time-point following
WNV-infection, determined after 2D-DIGE and iTRAQ analyses.
(B) Sub-network of cell death-related proteins built using IPA de
novo between WNV-L and mock-infected mice. Individual proteins
are represented as nodes colored in red and green corresponding
to up- and down-regulated proteins, respectively, while the nodes
(proteins) in white have been added by IPA to maximize the
network connectivity. The edges with arrowheads describe the
direct (continuous lines) and indirect (dotted lines) nature of the
interaction between these proteins. The different shapes of the
nodes represent functional classification of the proteins as
indicated in the legend.
(TIF)
Table S1 Experimental design for the 2D-DIGE analysis using
pH 3–10 IEF.
(DOC)
Table S2 Experimental design for the 2D-DIGE analysis using
pH 4–7 or 6–11 IEF.
(DOC)
Table S3 Experimental design for iTRAQ reagent-labeling of
brain sample pools.
(DOC)
Table S4 Proteins identified from the differential 2D DIGE
analysis (pH 4–7) after WNV infection.
(DOCX)
Table S5 Set of proteins identified by iTRAQ labeling and
tandem mass spectrometry as differentially expressed between
mock-, early- and late WNV-infected samples, indicating fold-
changes and p-values in each comparison, and GO subcellular
location and biological function.
(DOC)
Table S6 Ingenuity canonical pathways showing a significant
association using the set of proteins that are differentially expressed
between early- and mock-WNV infected samples [2Log(p-value)
.2.0].
(DOCX)
Table S7 Ingenuity canonical pathways showing a significant
association using the set of proteins that are differentially expressed
between late- and mock-WNV infected samples [2Log(p-value)
.2.0].
(DOCX)
Table S8 Ingenuity canonical pathways showing a significant
association using the dataset of proteins that are differentially
expressed between late- and early-WNV infected samples
[2Log(p-value) .2.0].
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